LEAH WILSON: Open Payments
NPI 1184872103 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,734 in 122 payments from 21 companies in 2025. Trend: 2023 $1,787 · 2024 $2,059 · 2025 $2,734
Food & beverage: $2,610Education: $124
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. | 19 | $358 |
| GlaxoSmithKline, LLC. | 18 | $326 |
| JAZZ PHARMACEUTICALS INC. | 7 | $258 |
| Regeneron Healthcare Solutions, Inc. | 8 | $203 |
| GENZYME CORPORATION | 6 | $196 |
| Verona Pharma, Inc. | 10 | $185 |
| AstraZeneca Pharmaceuticals LP | 8 | $184 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $177 |
| Janssen Scientific Affairs, LLC | 1 | $143 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $132 |
Products named: DUPIXENT, Arikayce, NUCALA, XYWAV, TEZSPIRE, Ohtuvayre, RYBREVANT, LUMRYZ.
Industry payments across FL — which companies pay providers there.
